Description

There has been a move towards using alternative medicine as a treatment for menopausal problems. The objectives of the study are to investigate the effects of Tualang Honey on the safety profiles, cardiovascular risk factors, change in hormones and also bone density among menopausal women. A randomized, controlled trial comparing the effects of Tualang Honey 20 gm/day for a 4-month intervention period was conducted. Tualang honey compared with low dose HRT had no demonstrable effects on the blood pressure measurement, body mass index and waist circumference.There was no significant change in biochemical parameters, lipid profile and blood sugar profile between the two groups. A significantly lower level of the FSH and LH levels were seen in the HRT group. Majority reported vaginal spotting and 35.7% reported actual per vaginal bleeding from the HRT group. There was no significant changes seen in the bone density. Daily intake of Tualang Honey at 20 mg/day for four month was found to be safe to use and have the same effect on bone densitometry.